17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Exclusion Criteria

• •No cardiac arrhythmia or uncontrolled dysrhythmia
• •No history of myocardial infarction within the past year
• •No New York Heart Association class III or IV heart failure
• •No other significant cardiac disease
• •No paroxysmal nocturnal dyspnea
• •No oxygen requirement
• •No AIDS
• •No history cardiac toxicity after receiving anthracyclines (e.g., doxorubicin hydrochloride, daunorubcin hydrochloride, mitoxantrone, bleomycin, or carmustine)
• •No pulmonary lymphoma
• •No known CNS lymphoma
• •QTc \>/= 450 msec for men
• •QTc \>/= 470 msec for women
• •LVEF \</= 40% by MUGA
• •No symptomatic congestive heart failure
• •No unstable angina pectoris
• •No symptomatic pulmonary disease requiring medication
• •No significant pulmonary disease including chronic obstructive or restrictive pulmonary disease
• •No dyspnea on or off exertion
• •No history of pulmonary toxicity after receiving anthracyclines (e.g., doxorubicin hydrochloride, daunorubcin hydrochloride, mitoxantrone, bleomycin, or carmustine)
• •Not pregnant or nursing
• •No other uncontrolled illness
• •No other active\* malignancy except nonmelanoma skin cancer or carcinoma in situ of the cervix
• •No prior allogeneic stem cell transplantation
• •No history of allergic reaction to eggs
• •No ongoing or active infection
• •No psychiatric illness or social situation that would preclude study compliance
• •No prior chest radiation or prior radiation that potentially included the heart in the field (e.g.,mantle).
• •No concurrent medications that prolong or may prolong QTc
• •No concurrent combination antiretroviral therapy for HIV-positive patients
• •No other concurrent investigational agents
• •No other concurrent anticancer therapy
• •No prior cardiac symptoms \>= grade 2
• •No sufficiently compromised pulmonary status (i.e., DLCO =\< 80%)
• •No history of serious ventricular arrhythmia (e.g., ventricular tachycardia or ventricular fibrillation \>= 3 beats in a row)
• •No prior pulmonary symptoms \>= grade 2
• •HIV negative
• •No active ischemic heart disease within 12 months.
• •No congenital long QT syndrome.
• •No left bundle branch block.